Stockscreener 앱 받기
23.83
2.63%
0.61
시간 외 거래:
23.96
0.13
+0.55%
전일 마감가:
$23.22
열려 있는:
$23.33
하루 거래량:
2.64M
Relative Volume:
1.25
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+5.16%
1개월 성능:
-1.00%
6개월 성능:
-9.36%
1년 성능:
-13.66%
1일 변동 폭
$23.02
$24.00
1주일 범위
$22.27
$24.00
52주 변동 폭
$22.27
$34.37
ARK Genomic Revolution ETF Stock (ARKG) Company Profile
명칭
ARK Genomic Revolution ETF
전화
855-406-1506
주소
-
ARKG을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
| ARKG | 23.83 | 0 | 0 | 0 | 0 | 0.00 |
| VTI | 296.51 | 417.53B | 0 | 0 | 0 | 0.00 |
| SPY | 595.51 | 372.57B | 0 | 0 | 0 | 0.00 |
| IVV | 598.45 | 253.41B | 0 | 0 | 0 | 0.00 |
| VB | 257.73 | 160.59B | 0 | 0 | 0 | 0.00 |
| QQQ | 505.79 | 124.43B | 0 | 0 | 0 | 0.00 |
ARK Genomic Revolution ETF 주식(ARKG)의 최신 뉴스
How To Trade (ARKG) - Stock Traders Daily
ARKK's holdings ranked by SA Quant Grades - MSN
Cathie Wood Keeps Betting On Amazon's 'Haul' Play: Ark Loads Up $6M Worth Of Shares - Benzinga
Unusually active option classes on open November 14th - TipRanks
5 Biggest Biotechnology ETFs in 2024 - Nasdaq
6 Stocks Cathie Wood is Buying | Investing - U.S News & World Report Money
Bullish Two Hundred Day Moving Average CrossARKG - Nasdaq
Thematic Portfolios Re-optimisation – Capturing Emerging Trends and Maximising Growth Potential - Syfe
Cathie Wood's ARK ETF Trades Amazon, Mercadolibre Stock By Investing.com - Investing.com Nigeria
Cathie Wood's ARK ETF Trades Amazon, Mercadolibre Stock - Investing.com
Cathie Wood Biotech Offers New Buy Point - Investor's Business Daily
Cathie Wood's Wednesday Exodus: Moderna And Jack Dorsey's Block Stocks Get Dumped - Benzinga
Cathie Wood positions for new tech boomand it doesn’t matter who wins the White House - CNBC
Crispr, Intellia, and Recursion gain as Ark ETFs boost stakes - MSN
When (ARKG) Moves Investors should Listen - Stock Traders Daily
Cathie Wood Buys $35 Million Of Amazon, Targets Crypto; Sells $42 Million Of This Stock - MSN
Tracking Cathie Wood’s ARK Invest 13F Portfolio – Q3 2024 Update (NYSEARCA:ARKK) - Seeking Alpha
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500 - Benzinga
Cathie Wood's Sky-High Vision: Dumps Shares Of Cybercab Touting Tesla For This eVTOL Play - Yahoo Finance
Best Biotech ETFs to Watch Right Now - The Motley Fool
7 popular thematic ETFs: Here’s how to invest in some of the hottest trends - MSN
Cathie Wood Continues To Sell Shares Of Jack Dorsey's Bitcoin-Focused Company Block — Ark Also Dumps Moderna, Robinhood Stock - MSN
(ARKG) Investment Analysis - Stock Traders Daily
Cathie Wood's Ark Invest Dumps Over $9M In Moderna Stock — Even With Post-COVID Plans On The Table - Yahoo Finance
Interest Rate Regimes And ARKG: Underperformance Explained (BATS:ARKG) - Seeking Alpha
ARK Genomic Revolution ETF (BATS:ARKG) Shares Sold by Capital Market Strategies LLC - Defense World
Learn to Evaluate (ARKG) using the Charts - Stock Traders Daily
ARK Invest teams up with eToro to launch portfolio of ETFs - ETF Stream
ARK Invest Teams Up With eToro to Debut Portfolio of ETFs - Yahoo Finance
Cathie Wood's Ark Invest Dumps Palantir Shares Amidst S&P 500 Inclusion And Extended AI Alliance - Benzinga
(ARKG) Proactive Strategies - Stock Traders Daily
Bridges Investment Management Inc. Has $332,000 Stock Holdings in ARK Genomic Revolution ETF (BATS:ARKG) - Defense World
Forget Quantum-Si Stock, Olink Acquirer Thermo Fisher Is a Better Long-Term Investment - MSN
Top ETFs Tracking CRISPR Gene Editing - The Motley Fool
Made-in-America Industrial Bets Are Dethroning the Likes of ARKK - Wealth Management
In the age of new tech, old-economy industrial bets still thriving - Financial Post
In Age of New Tech, Old-Economy Industrial Bets Still Thriving (ARKK, PAVE) - Bloomberg
How Rich Is Cathie Wood? What To Know About the Famed Stock Picker and ARK Invest CEO - MSN
908 Devices: Key Investor Now Selling (NASDAQ:MASS) - Seeking Alpha
Cathie Wood's Stock Shuffle: 1 Stock She's Loving, 1 She's Leaving - 24/7 Wall St.
ARK Genomic Revolution ETF (ARKG) 재무 분석
ARK Genomic Revolution ETF (ARKG)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.73%
자본화:
|
볼륨(24시간):